Helus Pharma (HELP) Market Performance and Comparative Analysis
Helus Pharma (ticker: HELP) closed the 24‑hour trading session on Thursday, 22 February 2026, at USD 10.77 per share, reflecting an increase of 2.34 % from the previous close. The price movement was recorded at 05:03 AM Central Europe time.
Current Trading Metrics
| Item | Value |
|---|---|
| Current share price | USD 10.77 |
| Shares outstanding | 73.1 million |
| Market capitalization | USD 770.9 million |
| Volume traded in last 24 h | USD 25.8 million |
| 200‑day simple moving average | USD 7.60 |
| 52‑week high | USD 15.15 (18 September 2026) |
| 52‑week low | USD 3.76 (9 June 2026) |
Over the past month, the stock has decreased by 19.91 %, indicating a significant decline relative to its recent performance.
Comparative Performance of Peer Stocks (Last 24 h)
| Company | Ticker | 24‑h change | Current price | Market cap | P/E ratio |
|---|---|---|---|---|---|
| Avino Silver & Gold Mines | ASM.TO | -0.95 % | CAD 7.30 | CAD 1.3 bn | 17.73 |
| Major Drilling | MDI.TO | -2.17 % | CAD 14.80 | CAD 1.3 bn | 48.5 |
| Morguard | MRC.TO | 0 % | CAD 114.26 | CAD 1.2 bn | 5.93 |
| Surge Energy | SGY.TO | -1.71 % | CAD 12.97 | CAD 1.3 bn | 29.0 |
| Rockpoint Gas Storage | RGSI.TO | +2.07 % | CAD 23.89 | CAD 1.2 bn | 4.02 |
These figures provide context for Helus Pharma’s recent performance relative to other firms within the Canadian stock market.
Company Background
Helus Pharma, listed on the NYSE MKT, is a Toronto‑based life‑sciences company focused on the development of psychedelic therapeutics. The firm emphasizes novel drug compounds, delivery mechanisms, and treatment protocols. Customers can access product information and services through the company’s website at www.cybin.com .
Note: The information presented is current as of the specified trading session and is intended for informational purposes only.
